About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Wednesday, October 29th, 2014

The QualityStocks
Daily Stock List


Hinto Energy, Inc. (HENI)

SmallCapVoice reported this week on Hinto Energy, Inc. (HENI), Pumps and Dumps, Otcstockexchange, Whisper from Wall Street did earlier, and we highlight the Company today, here at the QualityStocks Daily Newsletter.

Hinto Energy, Inc. engages in the acquisition, production, development, and exploration of oil and natural gas properties in the Rocky Mountain Basins. It has current producing properties in Utah and Montana. Moreover, the Company is working to acquire producing oil and natural gas properties that offer long term production opportunities and properties with proven oil and gas reserves. Its’ initial acquisitions are chiefly centered on the Uinta Basin of Utah.  OTCQB-listed, Hinto Energy is based in Greenwood Village, Colorado.

Hinto employs state-of-the-art technology for reservoir characterization, to discover by-passed reserves, and to evaluate unexploited resources made available with modern horizontal drilling. The technology the Company uses includes detailed petrophysical analysis, seismic interpretation and high-end geophysical analysis, shale evaluation, as well as 3D geological modeling.

Hinto Energy has acquired interests in roughly 5,700 gross and 4,900 net acres in the Natural Buttes area of Utah through farm out, with an additional potential farm out of up to 5,000 additional acres covering Dakota, Frontier, the Mancos formations, and Cedar Mountain in the Central part of the Uinta Basin, at Natural Buttes. Zones above 9,800 feet are excluded in its farm out. The overall targets will be zones from 9,800 feet to 16,000 feet.

In addition, the Company has acquired 9,200 gross and 9,000 net acres in the Cisco area of Utah. The properties have 35 wells, with 7 producing oil and the rest awaiting a connection to a gas pipeline or production evaluation.  At present, the property is producing from 5 to 15 barrels per day.

Furthermore, in June 2013, Hinto acquired a 95 percent working interest (WI) in 6 wells and approximately 1,160 gross leased acres in the Mason Lakes oil field in Musselshell, Montana. This past August, Hinto Energy announced the acquisition of a 100 percent WI in 8 oil wells and 640 acres in Musselshell County, Montana.

This month, Hinto Energy announced an agreement to take a 75 percent interest in an exploratory well to be drilled in Medina County, Ohio. Medina County is located on the Appalachian geosyncline. Hinto will retain a 75 percent non-operated interest in this initial well and any future wells developed on this property. Additionally, the Company has established a 36 square mile AMI (Area of Mutual Interest) with the operator. This could provide for additional drilling opportunities. The Operator is planning to drill and complete the first well during Q4 2014.

Hinto Energy, Inc. (HENI), closed Wednesday's trading session at $0.50, even for the day, on 2,600 volume with 2 trades. The average volume for the last 60 days is 6,219 and the stock's 52-week low/high is $0.35/$0.88.

TapImmune, Inc. (TPIV)

StreetAuthorityDaily reported recently on TapImmune, Inc. (TPIV), PennyStocks24, Pumps and Dumps, HEROSTOCKS, Stock Brain, VIP STOCK ALERTS, Liquid Pennies, Stockhunter.us, and Ceocast News did earlier, and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

TapImmune, Inc. is a vaccine technologies company with corporate headquarters in Seattle, Washington. The Company specializes in the development of innovative gene based immunotherapeutics and vaccines in the areas of oncology and infectious disease. It is developing cancer vaccines that combine the use of novel antigens together with its TAP expression technology. TapImmune’s technology has across-the-board applications in developing therapeutic and preventative vaccines. TapImmune’s shares trade on the OTC Markets’ OTCQB.

TapImmune is developing TAP-based prophylactic vaccines commercially suitable for the prevention of infectious diseases and as Biodefense agents. The Company’s lead product candidates include peptide and nucleic acid-based vaccine technologies. The design of these technologies is to restore and/or augment antigen presentation and subsequent recognition and killing of cancer cells by the immune system.   

The gene based TAP technology, as a vaccine component, has the potential to improve the efficacy of prophylactic and immunotherapeutic vaccines considerably. This is because it addresses a fundamental mechanism for T cell recognition and response. TAP expression also has the unique ability to enhance the effector function of mature killer T cells. This enhancement of effector function is potentially complementary to any/all vaccine approaches designed to enhance cellular responses.

TapImmune has developed an innovative, cost effective, immunotherapeutic vaccine expression and delivery system. The novel platform is termed TapImmune's PolyStart™ technology. The PolyStart and PAA (Peptide Antigen Array) technologies are straight forwardly and easily managed as a fast, versatile, plugin-and-play system. This means they can be configured to produce peptides for any desired pathogen.

TapImmune's PolyStart™ technology has been strategically designed to directly enhance the immune system's ability to stimulate either or both cytotoxic killer and helper T-cell reactive proprietary peptides, known and expected to be associated with one, or any cancer, infectious disease, or bio-threat.

Last week, TapImmune provided an update on the status of its PolyStartTM vaccine technology platform. It provided this update due to recent global concerns regarding pandemic infections and emerging viral threats such as Ebola and Enterovirus. The current focus of its PolyStart technology is on its cancer program (e.g., Her2/neu and folate receptor alpha antigens). However, TapImmune strongly reaffirms that this core technology has broad applicability in the development of vaccines for viral disease.

The use of its PolyStart technology increases the production of proprietary antigenic peptides of the vaccine by as much as four-fold. Consequently, this increases vaccine potency (presenting more antigen), and potentially making manufacturing and commercialization of large volume vaccines more cost effective.

TapImmune, Inc. (TPIV), closed Wednesday's trading session at $0.331, down 24.77%, on 202,967 volume with 84 trades. The average volume for the last 60 days is 68,496 and the stock's 52-week low/high is $0.2551/$7.00.

ScripsAmerica, Inc. (SCRC)

PennyStock24, Pumps and Dumps, Research Driven Investor, OTCtipReporter, Michael Stone, Growing Stocks Reports, SmallCapInvestorDaily, PennyStockScholar, Research Driven Alerts, and SmallCapVoice reported earlier on ScripsAmerica, Inc. (SCRC), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

OTCQB-listed ScripsAmerica, Inc. is a supplier of prescription, Over-the-Counter (OTC), and nutraceutical drugs. It delivers pharmaceutical products to a broad spectrum of end users across the health care industry via the largest pharmaceutical distributor in North America - McKesson Corp. End users include physicians' offices, retail pharmacies, long-term care sites, hospitals, and Government and home care agencies. ScripsAmerica has its headquarters in Tysons Corner, Virginia.

ScripsAmerica’s mission for consumers is to provide them the same high quality pharmaceutical, vitamin, and nutritional supplements that it supplies nationally to Hospitals & Nursing Homes. The Company provides a strong low cost system of broad-based U.S. national marketing, sales, and distribution of generic Rx, branded Rx, Over-the-Counter (OTC), nutraceuticals, and oral delivery OTC pharmaceuticals.  

ScripsAmerica has its RapiMed® product line. RapiMed® is an innovative pharmaceutical and OTC oral delivery method employing “Quick Melt Technology”. RapiMed® oral tablets dissolve in 30 seconds or less. They provide fast delivery of medicine without water. ScripsAmerica holds the exclusive rights to RapiMed®. The first RapiMed® product to enter the market is 80 mg and 160 mg Acetaminophen. This product focuses on children 2-11 years old and provides ease of administration and safe and effective dosage applications.

Concerning Pharmaceutical Contract Services, the Company’s service offering includes fulfilling prescription and OTC orders, labeling, packaging, and shipping. Current therapeutic categories serviced by ScripsAmerica include pain, arthritis, prenatal, urinary, and hormonal replacement drugs. Its other customers include Cardinal Health, Curtis Pharmaceuticals, MedVet and the United States Veterans Administration.

Earlier this month, ScripsAmerica announced that its managed specialty pharmacy reported $5,457,137 in approved orders during September 2014. The pharmacy's September revenue represented a 12 percent increase over the previous month and increased its annual run rate to more than $65 million.

Yesterday, ScripsAmerica announced that it will present at the SeeThruEquity Microcap Investor Conference to take place on Wednesday, November 12, 2014 at the Convene Midtown East in New York, New York. ScripsAmerica's team will provide a complete overview of the Company's business, highlighting consistent growth from its managed specialty pharmacy.

ScripsAmerica, Inc. (SCRC), closed Wednesday's trading session at $0.1235, up 10.27%, on 947,603 volume with 138 trades. The average volume for the last 60 days is 226,269 and the stock's 52-week low/high is $0.0815/$0.3089.

Coates International Ltd. (COTE)

SmallCapVoice and Wallstreetlivechat reported earlier on Coates International Ltd. (COTE), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Coates International Ltd. is a precision engineering company whose shares trade on the OTCQB. The Company specializes in the development of technologies that advance the standard combustion engine with the objectives of markedly improving fuel efficiency and power generation, and decreasing harmful emissions and long-term maintenance costs. Coates International engages in the development of the Coates Spherical Rotary Valve (CSRV) System. The CSRV system technology is used in piston-driven internal combustion engines. Coates International has its corporate office in Wall Township, New Jersey.

The design of the CSRV system technology is to replace the intake and exhaust conventional poppet valves used in piston-driven stationary, automotive, motorcycle, and marine engines. The CSRV contains two spherical rotary valves assembled on two separate shafts. One is for inlet and one is for exhaust. They rotate on ceramic carbon bearing with no oil lubrication.

The spheres do not make contact with any part of the housing. The seals are a floating type and consist of a ceramic material. They have two piston rings and are floating in a small cylinder-type chamber. They are activated by the compression and the combustion strokes of the engine. This allows 100 percent sealing effectiveness, upon compression.

The CSRV system technology is used in wide-ranging applications. These include engines for electric power generators for home use, industrial complexes, and grid installations; and engines to power motorcycles, automobiles, light trucks, heavy trucks, machinery, railroads, marine engines, military equipment, light aircraft, helicopters, lawn mowers, snowmobiles, jet skis, and more.

Coates International is now established in China for the manufacturing of the Coates CSRV Engines and Industrial Generators. Coates Power, Inc. Ltd. and two other Chinese companies have joined up with Coates Power to mass produce the Coates CSRV® products.

On October 2, 2014, Coates International shipped an Industrial Coates CSRV 150 KW Industrial Electric Power Natural Gas Generator to Coates Power, Inc. Ltd., Xianning City, Economic Development Zone, Hubei Province, People's Republic of China (PRC). It shipped a Coates CSRV Gen-Set and a V Twin Coates Heavy Cruiser Motorcycle Engine Model to Coates Power. These engines will be demonstrated under full load for the Chinese governments and other companies involved in the deal.

Last week, Coates International announced that the Company was contacted by The United States Office of the Secretary of Defense, who have expressed interest in the Coates Spherical Rotary Valve CSRV Engines for use in The United States Armed Forces. The meeting occurred on Wednesday, October 15, 2014. In attendance were US Government Officials from The United States Operational Energy Plans and Program Office of the Secretary of Defense.

Coates International Ltd. (COTE), closed Wednesday's trading session at $0.023, up 15.00%, on 426,200 volume with 13 trades. The average volume for the last 60 days is 332,869 and the stock's 52-week low/high is $0.0182/$0.06.

OSL Holdings, Inc. (OSLH)

PennyStocks24, Real Pennies, StockMarketQuote.us, 1-2-3 Stock Alerts, Penny Stock Circle, Fortune Stock Alerts, Pennystocktweeters.com, and Penny Stock Rumble reported on OSL Holdings, Inc. (OSLH), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OSL Holdings, Inc. is a development and technology company that lists on the OTC Markets’ OTCQB. The Company specializes in affluent, liberal markets with high disposal income. OSL’s intention is to operate a real-time loyalty rewards platform, which can facilitate the earning and redemption of rewards currency at the point of the transaction (online, mobile, at retail) and also on future transactions. In essence, the Company is a socially conscious business model committed to consumer advocacy, social activism, and the advancement of civil liberties through the power of commerce. OSL Holdings is based in Yardley, Pennsylvania.

In addition, on March 10, 2014, OSL Holdings announced its intention to enter the legal marijuana market when federal law permits, providing foundational work for branding, marketing, technology, and logistics to existing or emerging legal marijuana licensees.

The Company has three divisions: OSL Medical Services, Equality Rewards, and Shop4Equality. OSL Medical Services is a development platform focused on the development and financing of indoor gardens and cultivation facilities, production technologies, and merchandise and operational services for businesses in the herbal and supplement industry. The design of OSL Medical Services is to support its clients with branding, technology, marketing, logistics, and future planning services on a state-by-state basis across the U.S.

Equality Rewards is a platform agnostic rewards platform that capitalizes on the LGBT market. Shop4Equality is built on the Equality Rewards platform. It is a movement devoted to advancing LGBT civil rights through the power of commerce.

OSL Holdings announced this month the acquisition of Go Green Hydroponics, Inc. a privately-held hydroponics, indoor gardening and cultivation supply retail operation, located in Los Angeles, California. Go Green specializes in the sale of hydroponic cultivation equipment, mineral nutrient solutions and gardening resources and equipment. Go Green Hydroponics realized revenues of roughly $2.4 million in the first nine months of 2014. OSL Holdings acquired Go Green Hydroponics for $1.8 million subject to certain post-closing adjustments based on a target working capital amount.

Mr. Bob Rothenberg, OSL's CEO, said, "We are very excited about the acquisition of Go Green Hydroponics. Go Green is one of the most highly regarded brands in the vertical, continues to be a profitable business enjoying tremendous growth in the Los Angeles market."

Yesterday, OSL Holdings announced the development of a multi-tier, on-line cross platform social network and information repository solution. This will permit legal marijuana dispensaries and hydroponic gardening supply retailers to manage marketing, lead generation, as well as retail discovery.

The expectation is that the platform will become an ad supported online extension of the Company’s Go Green Hydroponics retail operations and other vertical venders. It will enable local and hyper local search with advanced querying capabilities. It is expected to launch in Q2 of fiscal 2015. 

OSL Holdings, Inc. (OSLH), closed Wednesday's trading session at $0.03, down 12.79%, on 844,864 volume with 73 trades. The average volume for the last 60 days is 681,481 and the stock's 52-week low/high is $0.003/$0.29.

ALR Technologies, Inc. (ALRT)

Clutch Investments and Penny Stock Pinnacle reported this month on ALR Technologies, Inc. (ALRT), TaglichBrothers did earlier, and we choose to report on the Company today, here at the QualityStocks Daily Newsletter.

OTCQB-listed ALR Technologies, Inc. is a medical device company providing remote monitoring and care facilitation for patients with chronic diseases. The Company has developed the Food and Drug Administration (FDA)-cleared and Health Insurance Portability and Accountability Act (HIPAA) compliant Health-e-Connect System, which collects data from blood glucose meters and uploads to a secure website. Founded in 1998, ALR Technologies is based in Richmond, Virginia.

Trained Facilitators use the Health-e-Connect System to attain efficiency of care among patients, clinicians and caregivers to improve outcomes and assist health plans to optimize their quality goals. At present, ALR Technologies is concentrating on diabetes. The Company will expand its services to cover other chronic diseases anchored on verifiable data.

Health-e-Connect evolved from the Company’s earlier product offerings also designed to assist a patient in meeting the goals in their Care Plan. ALR Technologies’ system goal is to assist patients to adhere to their care plan, improving the quality of diabetes care and making such care more cost effective to providers.

Earlier this month, ALR Technologies announced that it signed an agreement to launch a clinical outcomes study in Chile as a potential solution to the growing number of diabetic patients in Latin America. The upcoming trial follows the Company’s first large-scale commercial deployment of the Health-e-Connect system in the U.S. via the Kansas City Metropolitan Physicians Association in September.

The Latin America trial will treat 100 diabetic patients in Santiago, Chile. The expectation is that a successful trial will help establish a presence for the Company in the large Latin American market.

Last week, ALR announced that in a letter to Marilyn Tavenner, Administrator of the Center for Medicare and Medicaid Services (CMS), Bill Smith, President of ALR Technologies advocated for CMS reimbursement for continuous glucose monitoring systems (CGM) for Type 1 diabetes patients and higher-risk Type 2 patients. Nevertheless, Mr. Smith argued that most Type 2 patients should first be encouraged to look for Internet-based remote chronic care management and then to step up to CGM if they do not realize their health objectives on the more cost-effective, Internet-based monitoring.

ALR Technologies, Inc. (ALRT), closed Wednesday's trading session at $0.0259, up 12.61%, on 545,849 volume with 11 trades. The average volume for the last 60 days is 92,270 and the stock's 52-week low/high is $0.0153/$0.0599.

Optex Systems Holdings, Inc. (OPXS)

Wallstreetlivechat and Pumps and Dumps reported earlier on Optex Systems Holdings, Inc. (OPXS), and we highlight the Company today, here at the QualityStocks Daily Newsletter.

Founded in 1987, Optex Systems Holdings, Inc. is a foremost manufacturer of optical sighting systems and assemblies principally for Department of Defense (DoD) applications. The Company also manufactures and delivers numerous periscope configurations, rifle and surveillance sights, as well as night vision optical assemblies. It delivers its products directly to the military services and to prime contractors. Optex Systems Holdings is headquartered in Richardson, Texas and the Company lists on the OTCQB.
Optex Systems’ products are installed on various types of U.S. military land vehicles. These include the Abrams and Bradley fighting vehicles, Light Armored and Armored Security Vehicles. In addition, its products have been chosen for installation on the Stryker family of vehicles.

The Company manufactures the US Navy 20x 120mm Ship Binoculars and also brings inventive technology to vehicular mounted sighting systems. Its dismounted sighting systems work on weapon sights, night vision goggles, and any other sighting needs outside of ships and land vehicles. Additionally, Optex Systems can also meet Commercial (non-military) requirements. 

Optex Systems, Inc., a wholly-owned subsidiary of Optex Systems Holdings announced in December 2013, the issuance of U.S. Patent No. 13,357,802 titled "Multiple Spectral Single Image Sighting System Using Single Objective Lens Set." This invention presents a single image to both day and night sensors using precision optics. This sequentially allows the user to individually observe day, night, or day and night at the same time. Furthermore, it has proven to be particularly useful in light transition points experienced at dusk and dawn.

The Company’s products include its Laser Protected Periscopes. The Optex periscopes come with optional laser protection in both glass and plastic. This is to protect soldiers’ eyes as they do battle from various vehicle platforms, such as the Bradley, Stryker Family, and the M60 tank varieties.

Optex Systems’ products also include its DDAN/M36 Sights. It allows soldiers safer and more efficient field performance with the easy-to-use digital displays and optional laser protection. Optex Systems’ M36E3 combines day and night sights into one smaller device, which smoothly adjusts to any change in lighting.

Furthermore, the Company’s products include the Muzzle Reference Sensor. It allows for consistent accuracy during repeated fire by calibrating the tank barrel to the sighting system. Optex sensors are used in the Abrams A1, A2, Korean K1 and the Stryker Main Gun System.

Optex Systems Holdings, Inc. (OPXS), closed Wednesday's trading session at $0.0143, up 19.17%, on 65,487 volume with 3 trades. The average volume for the last 60 days is 71,903 and the stock's 52-week low/high is $0.005/$0.039.


The QualityStocks
Company Corner


Armco Metals Holdings, Inc. (AMCO)

The QualityStocks Daily Newsletter would like to spotlight Armco Metals Holdings, Inc. (AMCO). Today, Armco Metals Holdings, Inc. closed trading at $0.155, up 50.49%, on 2,583,647 volume with 1,622 trades. The stock’s average daily volume over the past 60 days is 88,016, and its 52-week low/high is $0.1001/$0.58.

Armco Metals Holdings, Inc. (AMCO), since its founding 10 years ago, has tirelessly worked to create low-cost, high-quality solutions to meet steel industry demands and achieve its goal to become the largest scrap steel recycler in China. The company operates through five subsidiaries located in key regions throughout the country to source, import, process, and distribute quality, environmentally friendly recycled scrap steel, as well as metal and non-ferrous metal ore.

Subsidiaries Armco Metals International, Ltd., Armco (Lianyungang) Renewable Metals, Inc., Armet (Lianyungang) Holdings, Inc., Henan Armco & Metawise Trading Co., Ltd., Armco Metals (Shanghai) Holding, Ltd. support Armco Metal’s overarching corporate mission and operate to provide the country’s steel production industry with sustainable, responsible solutions to its material needs. Aligned with China’s green initiatives, Armco Metals and its subsidiaries are helping the government reach its scrap metal consumption goal of 20% by 2015.

Leveraging long-standing relationships with more than 10 international metal suppliers, more than 100 small- and medium-sized Chinese steel production companies, and some of the country’s large state-run foundries, Armco Metals benefits from a steady and dependable supply of demand for the company’s high-quality product known for excellent market values.

Armco Metals’ management team has established a unique approach to business and environment by providing responsible solutions based on environmentally friendly practices; reliable, cost-effective sourcing; and quality metal products. Backed by more than 10 years of industry experience, company executives have successfully positioned the company as credible, dependable partner for customers, suppliers, and investors within the steel production market. Disclaimer

Armco Metals Holdings, Inc. Company Blog

Armco Metals Holdings, Inc. News:

Armco Metals Enters Into an Agreement With a Chile Supplier for Woodchips Purchase

Armco Metals Holdings Announces Financial Results for the Second Quarter of 2014

China's Ministry of Industry and Information Technology Approves Subsidiary

One World Holdings, Inc. (OWOO)

The QualityStocks Daily Newsletter would like to spotlight One World Holdings, Inc. (OWOO). Today, One World Holdings, Inc. closed trading at $0.0082, up 9.33%, on 1,592,879 volume with 18 trades. The stock’s average daily volume over the past 60 days is 636,068, and its 52-week low/high is $0.0033/$2.7692.

One World Holdings, Inc. (OWOO) subsidiary, The One World Doll Project, was established in 2010 to make a significant positive cultural impact through the doll category, transcending global and ethnic borders to create positive self-image in young women and girl around the world. Led by worldwide famous doll designer Stacy McBride-Irby, The One World Doll Project team has more than 50 collective years in the doll and toy industry and is dedicated and armed with the experience to ensure that the dolls are of the highest quality and value.

In 2013, the company released its Prettie Girls!™ line of multi-cultural fashion dolls uniquely designed with individual physical attributes, personal stories and hobbies, and goals and inspirations. For young girls, the dolls are a friend, a partner in play, and a glimpse of their biggest, brightest dreams. For young women, the dolls are a symbol of who they are and what they can achieve. For doll connoisseurs, The One World Doll Project promises stylish works of art that will become a vital part of a growing collectors’ market.

The One World Doll Project also has a Signature Celebrity Collection of Prettie Girls! and in 2013 released its first celebrity collectors doll modeled after supermodel Cynthia Bailey from The Real Housewives of Atlanta. Since the release of the doll, it has been showcased with Synthia on The Arsenio Hall Show, What Happens Live with Andy Cohen and The Bethenny Show.

Using a web-based sales model, One World Holdings plans to quickly capture significant market share in the dolls and stuffed toys space. After securing a strong online presence, the company will focus on brick and mortar retailing as it moves toward the ultimate pursuit of expanding worldwide. The company has established distribution deals with Toys “R” Us, HEB, dollgenie.com, Tuckers Toy Shop, pattycakedoll.com, and has recently expanded its retail presence internationally with the People’s Pharmacy storechain in the Central American country of Belize. The Prettie Girls! Dolls have been featured in national and international media spotlights like CNN, The Wall Street Journal, Jet Magazine, Bloomberg.com, Parade.com, Dolls Magazine, The Toy Book, The Houston Chronicle and Houston Business Journal, and TheStreet.com. Disclaimer

One World Holdings, Inc. Company Blog

One World Holdings, Inc. News:

The One World Doll Project Announces Financing Relationship With New York Hedge Fund, Blackbridge Capital

One World Holdings, Inc. Announces Engagement of QualityStocks Investor Relations Services

The One World Doll Project Announces New Online Distribution With Toys"R"UsŪ

Pan Global Corp. (PGLO)

The QualityStocks Daily Newsletter would like to spotlight Pan Global Corp. (PGLO). Today, Pan Global Corp. closed trading at $0.0199, up 39.16%, on 33,010 volume with 5 trades. The stock’s average daily volume over the past 60 days is 530,512, and its 52-week low/high is $0.009/$0.96.

Pan Global Corp. (PGLO) is focused on building the world’s green economy by developing, building, owning, and operating the necessary infrastructure. Current opportunities are currently concentrated on developing projects in India, specifically in the areas of hydro-power generation, solar PV, geo-thermal, sustainable agriculture, and green construction.

The India growth story is frequently compared to China, which has sustained above-average annual growth for three decades, whereas India’s take-off growth began at a later stage. During the last decade, India’s growth has averaged approximately 8% per year. India is poised for high GDP growth that will be sustained for decades to come.

Within the Indian market there are available various government-backed incentives programs, including those which provide direct tariff subsidies as well as market-based tariff support through renewable energy credits. Assessing project viability on a case by case basis, Pan Global seeks to invest in projects both as owner-developers and/or as partners with other developers.

Pan Global’s business strategy is an extension of the company’s commitment to improve human well-being and social equity, while significantly reducing environmental risks and ecological scarcities. By developing a series of highly environmentally sustainable and high ROI projects, Pan Global aims to accelerate business growth. Disclaimer

Pan Global Corp. Company Blog

Pan Global Corp. News:

Pan Global, Corp. Comments on Industry Report That the India Renewable Energy Market Opportunity Is Worth USD $10.5 Billion by 2017

Pan Global, Corp. Shareholder Update: Small-Hydro Plant Connected to Power Grid in Northern India

Pan Global, Corp. Increases Equity Stake in 5.7 MW Small-Hydro Plant in Northern India

Cleartronic, Inc. (CLRI)

The QualityStocks Daily Newsletter would like to spotlight Cleartronic, Inc. (CLRI). Today, Cleartronic, Inc. closed trading at $0.15, up 50.00%, on 1,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 8,239, and its 52-week low/high is $0.04/$0.5499.

Consorteum Holdings, Inc. (CLRI) is a technology holding company that creates and acquires operating subsidiaries to develop, manufacture and sell products, services and integrated systems to government agencies and business enterprises.

VoiceInterop, Inc., a wholly owned subsidiary, is a provider of patented IP communication gateways and communication software. Its gateways are marketed worldwide direct to customers as well as through a network of value added resellers. VoiceInterop has also developed an interoperable communication solution for use by airports. The company markets, installs and supports this interoperability solution directly to airports. International airports currently using the VoiceInterop communication solution include Dulles, Reagan, Omaha, Cincinnati, Green Bay and West Palm Beach.

A recent license agreement provides Cleartronic with the right to market Collabria LLC’s revolutionary ReadyOp™ command, control and communication platform. ReadyOp is a web-based application that integrates multiple databases and a robust communications platform supporting day-to-day activities for planning and managing small- and large-scale events. ReadyOp is designed for fast, efficient access to information and for communication with multiple persons, groups and agencies. ReadyOp is currently being used by numerous federal, state and local government agencies and private enterprises.

Backed by a management team committed to growing its business and finding ways to create value for shareholders, Cleartronic is well-positioned to grow in a broad array of markets. The company has a solid business plan in place that maximizes available resources for accelerated growth and has proven its ability to identify strong business opportunities. Disclaimer

Cleartronic, Inc. Company Blog

Consorteum Holdings, Inc. News:

Cleartronic, Inc. (CLRI) Announces Capitalization Benefit Plan and Expansion of Board of Directors

Cleartronic Announces License Agreement With Collabria LLC

Cleartronic, Inc. (CLRI) Developing 'Capitalization Benefit Plan'

Technology Applications International, Inc. (NUUU)

The QualityStocks Daily Newsletter would like to spotlight Technology Applications International, Inc. (NUUU). Today, Technology Applications International, Inc. closed trading at $1.03, up 1.98%, on 2,570 volume with 9 trades. The stock’s average daily volume over the past 60 days is 2,727, and its 52-week low/high is $0.85/$4.50.

Technology Applications International, Inc. (NUUU) is focused on producing, distributing, marketing and selling skincare products, in addition to engaging in the environmental management and water purification industries. The company conducts its business through two separate wholly owned subsidiaries: Rejuvel Int'l, Inc. and NueEarth, Inc.

Rejuvel Int'l, Inc. developed its skincare line of products using a NASA bioreactor to grow and expand three-dimensional fibroblast cells. Using exclusively licensed technology, licensed from the National Aeronautics and Space Administration and Administrators of the Tulane Educational Fund under U.S. Patent No. 6,730,498, the Rejuvel’s flagship anti-aging facial products trigger the multiplication of human fibroblast skin cells that rebuild skin for a firm, healthy and youthful appearance. The company has been awarded a “seal of approval” from the Space Certification program, setting a new standard for innovation in an industry projected to reach $114 billion in sales by 2015.

NueEarth, Inc. provides environmental management solutions and water purification techniques using a mobile electron beam accelerator unit which creates high-energy electrons that produce free radicals in the wastewater to decompose organic compounds or pollutants. The company has identified a number of different markets for this particle accelerator technology, including the removal of pollutants from wastewater, drinking water, municipal sludge and water that’s contaminated by the fracking process.

Technology Applications International’s management team is methodically establishing its brand in the marketplace with well-respected associations and strategic marketing initiatives. As the company continues to pursue direct consumer sales and other opportunities, it stands to do well with the foundation management has laid for growth. Disclaimer

Technology Applications International, Inc. Company Blog

Technology Applications International, Inc. News:

Rejuvel Int'l, Inc., a Wholly Owned Subsidiary of NUUU, Announced Today the Signing of a Distribution Agreement with Meditem Cyprus Limited

Rejuvel Int'l, Inc., a Wholly Owned Subsidiary of NUUU, Expands its International Branding Efforts with Placements of Multiple Full Page Print Advertisements in International Fashion and Health Magazines

NUUU Announces the Results of a Clinical Study that Tested the Efficacy of its Wholly Owned Subsidiary's Rejuvel Line of Anti-Aging Products that use NASA* Patented Technology

VistaGen Therapeutics, Inc. (VSTA)

The QualityStocks Daily Newsletter would like to spotlight VistaGen Therapeutics, Inc. (VSTA). Today, VistaGen Therapeutics, Inc. closed trading at $10.50, even for the day. The stock’s average daily volume over the past 60 days is 99, and its 52-week low/high is $5.20/$15.00.

VistaGen Therapeutics, Inc. (VSTA) is a biotechnology company applying stem cell technology for drug rescue and cell therapy. Drug rescue combines human stem cell technology with modern medicinal chemistry to generate new chemical variants ("drug rescue variants") of once-promising drug candidates that have been discontinued during late-stage preclinical development due to heart or liver safety concerns. VistaGen also focuses on cell therapy, or regenerative medicine, which includes repairing, replacing or restoring damaged tissues or organs

VistaGen's versatile stem cell technology platform, Human Clinical Trials in a Test Tube™, has been developed to provide clinically relevant predictions of potential heart and liver toxicity of promising new drug candidates long before they are ever tested on humans.

By more closely approximating human biology than conventional animal studies and other nonclinical techniques and technologies currently used in drug development, VistaGen's human stem cell-based bioassay systems can improve the predictability of the drug development cycle and lower the cost of new drug research and development by identifying product failures earlier in the cost curve. According to the Food and Drug Administration even only a ten percent improvement in predicting failure before clinical trials could save $100 million in development costs, which savings ultimately could be passed on to patients.

Using mature human heart cells produced from stem cells, VistaGen has developed and internally validated CardioSafe 3D™, a novel three-dimensional (3D) bioassay system for predicting the in vivo cardiac effects of new drug candidates before they are tested in humans. VistaGen is now focused on using CardioSafe 3D™ to generate up to two new, safer small molecule drug rescue variants every twelve to eighteen months. VistaGen anticipates that these drug rescue variants will be modified versions of once-promising new drug candidates that have been discontinued by pharmaceutical companies and academic research institutions because of heart toxicity concerns, despite substantial prior investment and positive efficacy data demonstrating their potential therapeutic and commercial benefits. In most cases, VistaGen plans to license or sell its new, safer drug rescue variants in strategic partnering arrangements with global pharmaceutical companies, arrangements providing VistaGen with both near term and downstream milestone payments and economic participation rights but without future development cost obligations.

AV-101, VistaGen's lead small molecule prodrug candidate, has successfully completed Phase I clinical development in the U.S. for treatment of neuropathic pain, a serious and chronic condition affecting millions of people worldwide, depression, and other neurological diseases and conditions. To date, the U.S. National Institutes of Health (NIH) has awarded VistaGen over $8.75 million for development of AV-101. Management anticipates strategically out-licensing AV-101 to a development and marketing partner in 2013.

VistaGen is also developing LiverSafe 3D™, a novel predictive liver toxicity and drug metabolism bioassay system for drug rescue applications. In parallel with drug rescue activities, the Company is funding early-stage nonclinical studies focused on potential cell therapy applications of its Human Clinical Trials in a Test Tube™ platform. Disclaimer

VistaGen Therapeutics, Inc. Company Blog

VistaGen Therapeutics, Inc. News:

VistaGen Receives Notice of Allowance for Canadian Patent, Further Expanding Stem Cell Technology Platform

VistaGen Announces Reverse Stock Split

VistaGen Receives Notice of Allowance for Canadian Patent Expanding Stem Cell Technology Platform

Ecrypt Technologies, Inc. (ECRY)

The QualityStocks Daily Newsletter would like to spotlight Ecrypt Technologies, Inc. (ECRY). Today, Ecrypt Technologies, Inc. closed trading at $0.115, even for the day. The stock’s average daily volume over the past 60 days is 9,520 and its 52-week low/high is $0.09/$0.179.

Ecrypt Technologies, Inc. (ECRY) is an emerging provider of military-strength data security solutions for enterprise, government, and military. The company empowers organizations with the freedom to communicate and collaborate without risk of liability, reputation damage, competitive threat, and other negative outcomes. Ecrypt is the trusted first choice for those looking to keep their communications confidential.

Today’s businesses struggle to guard against the increasing number of dangers as a result of complicated networks built with many different components that are often individually patched to address new threats, while neglecting to close security gaps in traditional solutions. On average, data breaches and subsequent fines and litigation cost a US business $534 million every year, the highest in the world according to the Ponemon Institute.

The flagship Ecrypt solution is an integrated email and encryption server that can be quickly deployed to fortify the security of corporate communication, including attachments and mobile devices, against data breaches while eliminating phishing threats, malware infections, and spam. By using Ecrypt’s paradigm-shifting technology, companies alleviate the need for separate encryption servers with their associated bloated administration and multiple points of weakness.

Ecrypt is well positioned to benefit from increasingly demanding data confidentiality regulations such as the Health Insurance Portability and Accountability Act (HIPAA), the Federal Information Security Management Act (FISMA), and Gramm-Leach-Bliley Act (GLBA). As a result of extensive market research and working directly with organizations in multi-billion dollar industries, the company fully understands the business community’s need to maintain confidentiality, prevent data breaches, comply with government regulations, and mitigate litigation risks. Disclaimer

Ecrypt Technologies, Inc. Blog

Ecrypt Technologies, Inc. News:

Ecrypt Technologies, Inc. Appoints Urvashi Mehra as VP of Global Healthcare Solutions

Ecrypt Technologies Inc.'s Chief Executive Officer, Dr. Thomas A. Cellucci, is the First American Elected to EECSA's Board

Safe America Appoints Ecrypt CEO to Head Drive


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



Real Pennies




Penny Stock Whispers

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251